Hedgehog signaling in human medullary thyroid carcinoma: A novel signaling pathway

Thyroid

Volumn 23, Issue 9, 2013, Pages 1119-1126

  Bohinc, Brittany ^a   Michelotti, Gregory ^a   Diehl, Anna Mae ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; VISMODEGIB; ANILIDE; CYCLOHEXYLAMINE DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GLI2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MESSENGER RNA; NUCLEAR PROTEIN; PYRIDINE DERIVATIVE; SAG COMPOUND; SHH PROTEIN, HUMAN; SMO PROTEIN, HUMAN; THIOPHENE DERIVATIVE; TUMOR MARKER;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID MEDULLARY CARCINOMA; WESTERN BLOTTING; CARCINOMA; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; THYROID TUMOR; TIME FACTOR; TUMOR CELL LINE; UPREGULATION;

ANILIDES; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOMA, NEUROENDOCRINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOHEXYLAMINES; HEDGEHOG PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIOPHENES; THYROID NEOPLASMS; TIME FACTORS; UP-REGULATION;

EID: 84884146030     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0474     Document Type: Article

References (32)

1. Valle LA, Kloos RT 2011 The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 96:E109-113.
2. Marini F, Falchetti A, Del Monte F, et al. 2006 Multiple endocrine neoplasia type 2. Orphanet J Rare Dis 1:45.
3. Jimenez C, Hu MI, Gagel RF 2008 Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 37: 481-496, x-xi.
4. Jeong J, Mao J, Tenzen T, et al. 2004 Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev 18:937-951.
5. Ahlgren SC, Thakur V, Bronner-Fraser M 2002 Sonic Hedgehog rescues cranial neural crest from cell death induced by ethanol exposure. Proc Natl Acad Sci USA 99:10476-10481.
6. Ahlgren SC, Bronner-Fraser M 1999 Inhibition of Sonic Hedgehog signaling in vivo results in craniofacial neural crest cell death. Curr Biol 9:1304-1314.
7. Berger CL, de Bustros A, Roos BA, et al. 1984 Human medullary thyroid carcinoma in culture provides a model relating growth dynamics, endocrine cell differentiation, and tumor progression. J Clin Endocrinol Metab 59:338-343.
8. Cooley LD, Elder FF, Knuth A et al. 1995 Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell lines. Cancer Genet Cytogenet 80: 138-149.
9. Xu X, Ding H, Rao G, et al. 2012 Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in cell proliferation. Endour Relat Cancer 19:167-179.
10. Sicklick JK, Li YX, Choi SS, et al. 2005 Role for Hedgehog signaling in heptic stellate cell activation and viability. Lab Invest 85:1368-1380.
11. Sippel R, Kunnimalaiyaan M, Chen H 2008 Current management of medullary thyroid cancer. The Oncologist 13:539-547.
12. Kodama Y, Asai N, Kawai K, et al. 2005 The RET protooncogene: a molecular therapeutic target in thyroid cancer. Cancer Sci 96:143-148.
13. Asai N, Jijiwa M, Enomoto A, et al. 2006 RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease. Pathol Int 56:164-172.
14. Wells SA Jr, Robinson BG, Gagel RF, et al. 2012 Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double blind phase III trial. J Clin Oncol 30:134-141.
15. Lanzi C, Cassinelli G, Nicolini V, et al. 2009 Targeting RET for thyroid cancer therapy. Biochem Pharmacol 77:297-309.
16. Romei C, Mariotti S, Fugazzola L, et al. 2010 Multiple endocrine neoplasia type 2 syndromes (MEN2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol 163:301-308.
17. Shimaoka K, Schoenfeld DA, DeWys WD, et al. 1985 A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56:2155-2160.
18. De Besi P, Busnardo B, Toso S, et al. 1991 Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest 14:475-480.
19. Wu LT, Averbuch SD, Ball DW, et al. 1994 Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine. Cancer 73:432-436.
20. Orlandi F, Caraci P, Berruti A, et al. 1994 Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. Ann Oncol 5:763-765.
21. Scales SJ, de Sauvage FJ 2009 Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 30:303-312.
22. Johnson RL, Rothman AL, Xie J, et al. 1996 Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-1671.
23. Pietsch T, Waha A, Koch A, et al. 1997 Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophilia patched. Cancer Res 57:2085-2088.
24. Raffel C, Jenkins RB, Frederick L, et al. 1997 Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57: 842-845.
25. Vorechovsky I, Tingby O, Hartman M, et al. 1997 Somatic mutations in the human homologue of Drosophilia patched in primitive neuroectodermal tumours. Oncogene 15:361-366.
26. Fan L, Pepicelli CV, Dibble CC, et al. 2004 Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145:3961-3970.
27. Dierks C, Grbic J, Zirlik K, et al. 2007 Essential role of stromally induced Hedgehog signaling in B-cell malignancies. Nat Med 13:944-951.
28. Yauch RL, Gould SE, Scales SJ, et al. 2008 A paracrine requirement for Hedgehog signaling in cancer. Nature 455:406-410.
29. Gershon TR, Shirazi A, Qin LX et al. 2009 Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis. PloS One 4:e7491.
30. Von Hoff DD, LoRusso PM, Rudin CM, et al. 2009 Inhibition of the Hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361:1164-1172.
31. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. 2012 Inhibiting the Hedgehog pathway in patients with the basalcell nevus syndrome. N Engl J Med 366:2180-2188.
32. Sekulic A, Migden MR, Oro AE, et al. 2012 Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366:2171-2179.